Pink Sheet Team
Editorial Team
The policy and regulatory insights advantage for biopharma decision-makers around the globe.
Latest From Pink Sheet Team
In Case You Missed It … News On Cheaper CAR-Ts, EU Approval Records, And More
We clean out your Martin Luther King Day inbox so you don't have to.
In Case You Missed It: RWE, US FDA Commissioner Hearings, 2021 Approval Trends, And More
Start the new year by catching up with these key stories posted by the Pink Sheet in late December.
Pink Sheet Podcast: Califf Confirmation Hearing, COVID-19 Vaccine Changes, Cancer Drugs From China
Pink Sheet reporters and editors discuss US FDA commissioner nominee Robert Califf’s Senate confirmation hearing, new COVID-19 vaccine recommendations from the US CDC, and issues related to US approval of China-developed cancer drugs.
In Case You Missed It: China’s ‘Dual Circulation’ Policy, Fixing Safety Data ‘Overload,’ And More
We clean out your Thanksgiving inbox so you don't have to.
Pink Sheet Podcast: COVID-19 Boosters For Adults, Aduhelm And Part B, Califf For FDA Commissioner
Pink Sheet reporters and editors discuss the authorization of COVID-19 vaccine booster shots for all adults, Aduhelm’s impact on Medicare Part B and rejection by EMA, and the nomination of ex-FDA commissioner Robert Califf for another term.
Pink Sheet Podcast: Drug Price Negotiations, Kids COVID Vaccine Deployed, FDA Chief Scientist Leaves
Pink Sheet reporters and editors discuss the congressional agreement to allow Medicare drug pricing negotiation, the authorization of the Pfizer/BioNTech vaccine for children age 5 to 11, and the departure of the US FDA’s Chief Scientist.